Chen et al. revealed that TLR4/NADPH oxidase 4 (NOX4) pathways can induce the activation of autophagy and ferroptosis in rats after heart failure, suggesting that TLR4 is a promising therapeutic agent for heart failure by retarding autophagy/ferroptosis-mediated cell death (Chen et al., 2019). Here, NOX4 is linked to heart failure.